Enclomiphene vs. Clomid for Men: Evidence, Risks and Fertility

Physician-reviewed men's hormone education

Enclomiphene vs. Clomid for Men

Both can stimulate the body's own testosterone production in selected men, but they are not identical—and the evidence does not justify calling enclomiphene universally “safer” or “better.”

Medically reviewed by Dr. Timothy Mackey
Medical Director · Updated September 2026

What is the difference between enclomiphene and Clomid?

Clomiphene citrate is a mixture of two stereoisomers: enclomiphene and zuclomiphene. Enclomiphene is relatively anti-estrogenic at the hypothalamus and helps reduce estrogen-mediated negative feedback, increasing GnRH signaling and pituitary LH and FSH. Zuclomiphene has different pharmacologic characteristics and persists longer in the body.

Pure enclomiphene removes the zuclomiphene component, which is one reason researchers have studied whether it can provide a more predictable endocrine response. However, mechanistic differences do not by themselves prove superior long-term clinical outcomes.

How do SERMs raise testosterone?

In men with secondary or functional hypogonadism and low or inappropriately normal LH, reducing estrogen feedback at the hypothalamus/pituitary can increase LH and FSH. LH then stimulates Leydig cells to produce testosterone. This requires functioning pituitary signaling and responsive testes.

That makes SERMs fundamentally different from testosterone replacement therapy, which supplies exogenous testosterone and typically suppresses LH and FSH.

Does enclomiphene actually raise testosterone?

Yes, in the populations studied. Randomized trials in men with secondary hypogonadism found that enclomiphene increased serum testosterone, LH and FSH. In trials comparing enclomiphene with topical testosterone gel, both increased testosterone, but enclomiphene maintained gonadotropins and sperm concentrations while testosterone gel suppressed them.

A 2025 systematic review and meta-analysis of randomized trials found that SERM therapy with clomiphene or enclomiphene significantly increased total testosterone, LH and FSH compared with placebo. The evidence therefore supports SERMs as legitimate therapeutic tools in selected men—not merely as “testosterone boosters.”

Is enclomiphene safer than Clomid?

We would not state that as an established fact. A 2024 retrospective study of 66 men who received clomiphene and later enclomiphene reported fewer documented adverse effects during enclomiphene treatment and a smaller increase in estradiol. That finding is clinically interesting, but it was not a large randomized head-to-head safety trial.

Both therapies require individualized risk assessment and monitoring. Visual symptoms, mood changes, headache and other adverse effects have been reported with SERM therapy. Long-term comparative safety data remain more limited than the marketing language sometimes used online suggests.

What about fertility?

This is one of the most important distinctions from exogenous testosterone. Because SERMs stimulate rather than suppress pituitary LH and FSH, they can be useful when preserving endogenous testicular function is important. Enclomiphene trials specifically demonstrated preservation of sperm concentrations compared with testosterone gel.

The AUA/ASRM male infertility guideline notes that SERMs such as clomiphene may be considered in selected infertile men with low testosterone, particularly when LH is low or normal. Men actively trying to conceive should be evaluated according to fertility goals, including semen analysis when appropriate.

Read our TRT and fertility guide and hCG therapy guide.

Is enclomiphene an add-on to TRT?

Not automatically. Enclomiphene has primarily been studied as a way to stimulate endogenous testosterone production in men with secondary hypogonadism, including as an alternative to exogenous testosterone. Evidence for routinely adding it to every TRT protocol is much weaker.

When a man is already receiving exogenous testosterone, the resulting negative feedback suppresses the same hypothalamic-pituitary axis that a SERM is attempting to stimulate. Whether a SERM has a role depends on the actual goal—fertility, endogenous testosterone recovery, testicular function, or treatment of secondary hypogonadism.

For a deeper discussion, see Enclomiphene for Men on TRT.

Is enclomiphene better than testosterone therapy?

Neither treatment is universally “better.” They solve different problems. A man with secondary hypogonadism who wants to preserve fertility may value a therapy that maintains LH, FSH and sperm production. A man with primary testicular failure is less likely to respond adequately to a SERM because the testes themselves cannot respond normally to increased LH.

The appropriate treatment depends on symptoms, repeated morning testosterone measurements, LH/FSH, fertility plans, medical history, examination and the cause of testosterone deficiency. The goal is not to push every patient toward the same medication.

FDA approval and prescribing status

Clomiphene is FDA-approved for ovulatory dysfunction in women; its use in men is off-label. Enclomiphene has been studied extensively for male secondary hypogonadism but is not FDA-approved as a standalone drug for treating male hypogonadism in the United States. Patients should understand the regulatory status of any medication being considered and discuss sourcing, risks and monitoring with the prescribing clinician.

Frequently asked questions

Is enclomiphene just Clomid without zuclomiphene?

Conceptually, enclomiphene is the trans-isomer of clomiphene and does not contain the zuclomiphene isomer present in clomiphene citrate. The resulting pharmacology is different, but that does not make the two drugs interchangeable in every clinical situation.

Can enclomiphene preserve sperm production?

Trials in men with secondary hypogonadism found that sperm concentrations were maintained during enclomiphene treatment, while testosterone gel reduced spermatogenesis. Individual fertility still requires appropriate evaluation.

Does Clomid raise testosterone in men?

It can. Clomiphene has been used off-label in men and studies show increases in testosterone in appropriately selected patients. Response varies and depends on an intact hypothalamic-pituitary-testicular axis.

Which has fewer side effects?

Limited comparative data suggest enclomiphene may have a favorable tolerability profile, but evidence is insufficient to promise that it will cause fewer adverse effects in every patient.

Should I use enclomiphene instead of TRT if I want children?

That decision requires individualized fertility and hormone evaluation. Exogenous testosterone can suppress spermatogenesis, while SERMs or hCG may be considered in selected men. A semen analysis is important when fertility is an active goal.

Medical sources

• 2025 systematic review and meta-analysis: clomiphene or enclomiphene for male hypogonadism
• Randomized phase II trial: enclomiphene, testosterone and sperm preservation
• Phase III trials: enclomiphene raises testosterone and preserves sperm counts
• Comparative safety and efficacy of enclomiphene and clomiphene
• AUA/ASRM Male Infertility Guideline

This article is educational and does not replace individualized medical care. Prescription hormone and fertility medications should be selected and monitored by an appropriately licensed clinician.